7 completed. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 7 |
Follow SSRI: new trials by email Literature Review of SSRI trials Research Report on SSRI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder Vortioxetine 10-20 mg, Placebo, SSRI - Major Depressive Disorder | Phase 3 | Completed | H. Lundbeck A/S | 151 | 2014-10-01 | 2017-05-24 |
| A Study of LY2216684 in Participants With Major Depression Disorder LY2216684, SSRI - Major Depressive Disorder | Phase 3 | Completed | Eli Lilly and Company | 288 | 2011-08-01 | 2018-10-25 |
| A Study in Prevention of Re-emergence of Depression Symptoms LY2216684, Placebo, SSRI - Major Depressive Disorder | Phase 3 | Completed | Eli Lilly and Company | 1249 | 2011-05-01 | 2018-04-17 |
| A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment LY2216684, Placebo, SSRI - Major Depressive Disorder (MDD) | Phase 3 | Completed | Eli Lilly and Company | 1480 | 2011-03-01 | 2018-04-24 |
| A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor LY2216684, Placebo, SSRI - Major Depressive Disorder | Phase 3 | Completed | Eli Lilly and Company | 1056 | 2011-03-01 | 2018-04-27 |
| A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder LY2216684, Placebo, SSRI - Major Depressive Disorder | Phase 3 | Completed | Eli Lilly and Company | 1416 | 2010-11-01 | 2018-04-17 |
| A Safety Study in Participants With Major Depressive Disorder LY2216684 (edivoxetine), SSRI - Depressive Disorder, Major | Phase 3 | Completed | Eli Lilly and Company | 608 | 2010-10-01 | 2018-04-17 |
Depressive Disorder, Major (7) · Depression (1)
Eli Lilly and Company (6) · H. Lundbeck A/S (1)
United States (5) · Germany (3) · Japan (3) · Slovakia (3) · Belgium (2) · Croatia (2) · Finland (2) · Mexico (2) · Puerto Rico (2) · Russia (2) · Spain (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1)
PMID 27035159, PMID 27685842, PMID 25894953
2014 (1)